TP53 and endometrial carcinoma: The ESGO/ESTRO/ESP guidelines integrate the TCGA molecular classification into clinical practice by using more affordable methods while still providing a framework for risk stratification and management of endometrial carcinoma POLE-mutated, mismatch repair (MMR)-deficient, p53-abnormal, and “no specific molecular profile” (NSMP).